UK markets closed
  • FTSE 100

    7,043.61
    +80.28 (+1.15%)
     
  • FTSE 250

    22,336.10
    +266.80 (+1.21%)
     
  • AIM

    1,236.38
    +11.54 (+0.94%)
     
  • GBP/EUR

    1.1602
    -0.0025 (-0.21%)
     
  • GBP/USD

    1.4096
    +0.0044 (+0.32%)
     
  • BTC-GBP

    32,982.79
    -1,124.05 (-3.30%)
     
  • CMC Crypto 200

    1,398.33
    +39.77 (+2.93%)
     
  • S&P 500

    4,173.85
    +61.35 (+1.49%)
     
  • DOW

    34,382.13
    +360.73 (+1.06%)
     
  • CRUDE OIL

    65.51
    +1.69 (+2.65%)
     
  • GOLD FUTURES

    1,844.00
    +20.00 (+1.10%)
     
  • NIKKEI 225

    28,084.47
    +636.47 (+2.32%)
     
  • HANG SENG

    28,027.57
    +308.87 (+1.11%)
     
  • DAX

    15,416.64
    +216.94 (+1.43%)
     
  • CAC 40

    6,385.14
    +96.81 (+1.54%)
     

Sabra Health Care REIT, Inc. Announces First Quarter 2021 Earnings Release Date and Conference Call

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
  • Oops!
    Something went wrong.
    Please try again later.

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2021 first quarter earnings release on May 5, 2021.

A conference call with a simultaneous webcast to discuss the 2021 first quarter results will be held on Thursday, May 6 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 844-862-3710. For participants outside the U.S., the dial-in number is 612-979-9902. The conference ID number is 6384625.

The webcast URL is https://edge.media-server.com/mmc/p/zghrxwo7. A digital replay of the call will be available on our website at www.sabrahealth.com.

About Sabra

Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210422005953/en/

Contacts

Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com